机构:[1]Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing (100700), China[2]Department of Rehabilitation, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing (100078), China[3]Department of Emergency, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing (100010), China[4]Department of Neurology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou (510120), China广东省中医院[5]Department of Neurology, the First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou (450000), China[6]Department of Neurology, the Affiliated Hospital of Changchun University of Chinese Medicine, Changchun (130017), China[7]Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing (100700), China[8]Department of Neurology, Taiyuan Hospital of Traditional Chinese Medicine, Taiyuan (140107), China
Objective To delineate the onset and recurrence characteristics of noncardiogenic ischemic stroke patients in China. Methods A prospective, multicenter and registry study was carried out in 2,558 patients at 7 representative clinical sub-centers during November 3, 2016 to February 17, 2019. A questionnaire was used to collect information of patients regarding CM syndromes and constitutions and associated risk factors. Additionally, stroke recurrence was defined as a primary outcome indicator. Results A total of 327 (12.78 %) patients endured recurrence events, 1,681 (65.72%) were men, and the average age was 63.33 +/- 9.45 years. Totally 1,741 (68.06%) patients suffered first-ever ischemic stroke, 1,772 (69.27%) patients reported to have hypertension, and 1,640 (64.11%) of them reported dyslipidemia, 1,595 (62.35%) patients exhibited small-artery occlusion by The Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification. Specifically, 1,271 (49.69%) patients were considered as qi-deficient constitution, and 1,227 (47.97%) patients were determined as stagnant blood constitution. There were 1,303 (50.94%) patients diagnosed as blood stasis syndrome, 1,280 (50.04%) patients exhibited phlegm and dampness syndrome and 1,012 (39.56%) patients demonstrated qi deficiency syndrome. And 1,033 (40.38%) patients declared intracranial artery stenosis, and 478 (18.69%) patients reported carotid artery stenosis. The plaque in 1,508 (41.36%) patients were of mixed. Particularly, 41.09% of them demonstrated abnormal levels of glycated hemoglobin levels. Conclusions Recurrence in minor and small-artery stroke cannot be ignored. Hypertension, dyslipidemia, abnormal HbA1c, intracranial artery stenosis and carotid plaque were more common in stroke patients. Particularly, phlegm-dampness and blood stasis syndromes, as well as qi deficiency and blood stasis constitutions, were still the main manifestations of stroke. (Trial registration at ClinicalTrials.gov No. NCT03174535)
基金:
Supported by Traditional Chinese Medicine Research Special
Project (No. 201507003-8) and Construction of a Service
System for Traditional Chinese Medicine Preventive Treatment
of Disease (No. 2018YFC1704705)
第一作者机构:[1]Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing (100700), China[2]Department of Rehabilitation, Dongfang Hospital, Beijing University of Chinese Medicine, Beijing (100078), China
通讯作者:
推荐引用方式(GB/T 7714):
Gao Yang,Xie Yan-Ming,Wang Gui-Qian,et al.Onset and Recurrence Characteristics of Chinese Patients with Noncardiogenic Ischemic Stroke in Chinese Medicine Hospital[J].CHINESE JOURNAL OF INTEGRATIVE MEDICINE.2022,28(6):492-500.doi:10.1007/s11655-022-3306-4.
APA:
Gao, Yang,Xie, Yan-Ming,Wang, Gui-Qian,Cai, Ye-Feng,Shen, Xiao-Ming...&Wei, Rui-Li.(2022).Onset and Recurrence Characteristics of Chinese Patients with Noncardiogenic Ischemic Stroke in Chinese Medicine Hospital.CHINESE JOURNAL OF INTEGRATIVE MEDICINE,28,(6)
MLA:
Gao, Yang,et al."Onset and Recurrence Characteristics of Chinese Patients with Noncardiogenic Ischemic Stroke in Chinese Medicine Hospital".CHINESE JOURNAL OF INTEGRATIVE MEDICINE 28..6(2022):492-500